# OnCo record medpacto (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/medpacto/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "medpacto" ;
  schema:name "MedPacto"@en ;
  schema:alternateName "MedPacto Inc."@en, "메드팩토"@en, "KOSDAQ:235980"@en ;
  schema:description "MedPacto is a South Korean biotech whose oral TGF-beta receptor inhibitor vactosertib is being tested with chemotherapy and checkpoint inhibitors in colorectal, stomach and bone-marrow cancers."@en ;
  schema:url <https://onco.cc/companies/medpacto/>, <https://www.medpacto.com/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:citation <https://www.medpacto.com/> ;
  onco:tag "drug-maker" ;
  schema:addressCountry "KR" ;
  onco:drugs <https://onco.cc/drugs/vactosertib/> .
